ArticleBreast cancer research : BCR2021

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1.

Silvana Mouron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.